| [1] |
Bates D, Schultheis BC, Hanes MC, et al. A comprehensive algorithm for management of neuropathic pain[J]. Pain Med, 2019, 20: S2-S12.
|
| [2] |
刘强,邱东宇,菅敏钰,等.吗啡通过激活ERK1/2信号通路促进胶质母细胞瘤细胞增殖[J].基础医学与临床,2018,38:507-511.
|
| [3] |
Marchesi N, Govoni S, Allegri M. Non-drug pain relievers active on non-opioid pain mechanisms[J]. Pain Practice, 2022, 22: 255-275.
|
| [4] |
Scarpellino G, Genova T, Munaron L. Purinergic P2X7 receptor: a cation channel sensitive to tumor microenvironment[J]. Recent Pat Anti Drug Discov, 2019,14:32-38.
|
| [5] |
Drill M, Jones NC, Hunn M, et al. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer[J]. Purinergic Signal, 2021, 17: 215-227.
|
| [6] |
Song JG, Liu L. Naringenin alleviates bone cancer pain in rats via down-regulating spinal P2X7R/PI3K/AKT signaling: involving suppression in spinal inflammation[J]. Mol Cell Toxicol, 2021, 17: 475-484.
|
| [7] |
Jiang LH, Caseley EA, Muench SP, et al. Structural basis for the functional properties of the P2X7 receptor for extracellular ATP[J]. Purinergic Signal, 2021, 17: 331-344.
|
| [8] |
von Mücke-Heim IA, Deussing JM. The P2X7 receptor in mood disorders: emerging target in immunopsychiatry, from bench to bedside[J]. Neuropharmacology, 2022: 109366.doi: 0.1016/j.neuropharm.2022.109366.
|
| [9] |
Kan LK, Williams D, Drummond K, et al. The role of microglia and P2X7 receptors in gliomas[J]. J Neuroimmunol, 2019, 332: 138-146.
|
| [10] |
Wu Y, Shen Z, Xu H, et al. BDNF participates in chronic constriction injury-induced neuropathic pain via transcriptionally activating P2X7 in primary sensory neurons[J]. Mol Neurobiol, 2021, 58: 4226-4236.
|
| [11] |
Dong Y, Chen Y, Zhang L, et al. P2X7 receptor acts as an efficient drug target in regulating bone metabolism system[J]. Biomed Pharmacother, 2020, 125: 110010.doi: 10.1016/j.biopha.2020.110010.
|
| [12] |
Platania CBM, Lazzara F, Fidilio A, et al. Blood-retinal barrier protection against high glucose damage: the role of P2X7 receptor[J]. Biochem Pharmacol, 2019, 168: 249-258.
|
| [13] |
Zhang W, Hu C, Zhu Z, et al. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties[J]. Biomed Pharmacother, 2020, 125: 109844.doi: 10.1016/j.biopha.2020.109844.
|
| [14] |
Felix R, Muñoz-Herrera D, Corzo-López A, et al. Ion channel long non-coding RNAs in neuropathic pain[J]. Pflugers Arch, 2022, 474: 457-468.
|
| [15] |
McGinnis A, Ji RR. The similar and distinct roles of satellite glial cells and spinal astrocytes in neuropathic pain[J]. Cells, 2023, 12: 965.doi: 10.3390/cells12060965.
|
| [16] |
Bravo D, Zepeda-Morales K, Maturana CJ, et al. NMDA and P2X7 receptors require pannexin 1 activation to initiate and maintain nociceptive signaling in the spinal cord of neuropathic rats[J]. Int J Mol Sci, 2022, 23: 6705.doi: 10.3390/ijms23126705.
|
| [17] |
Zhou J, Zhang X, Zhou Y, et al. Up-regulation of P2X7 receptors contributes to spinal microglial activation and the development of pain induced by BmK-I[J]. Neurosci Bull, 2019, 35: 624-636.
|
| [18] |
Wu P, Wu X, Zhou G, et al. P2X7 receptor-induced bone cancer pain by regulating microglial activity via NLRP3/IL-1beta signaling[J]. Pain Physician, 2022, 25(8): E1199-E1210.
|
| [19] |
Wu P, Wang Y, Liu Y, et al. Emerging roles of the P2X7 receptor in cancer pain[J]. Purinergic Signal, 2022: 1-10.
|
| [20] |
Zou Y, Yang R, Li L, et al. Purinergic signaling: a potential therapeutic target for depression and chronic pain[J]. Purinergic Signal, 2021: 1-10.
|
| [21] |
Zhang W, Zhu Z, Liu Z. The role and pharmacological properties of the P2X7 receptor in neuropathic pain[J]. Brain Res Bull, 2020, 155: 19-28.
|
| [22] |
Oskolkova OV, Godschachner V, Bochkov VN. Off-target anti-inflammatory activity of the p2x7 receptor antagonist AZ11645373[J]. Inflammation, 2017, 40: 530-536.
|
| [23] |
Honore P, Donnelly-Roberts D, Namovic MT, et al. A-740003[N-(1-{[(cyanoimino)(5-quinolinylamino) methyl] amino}-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl) acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat[J]. J Pharmacol Exp Ther, 2006, 319: 1376-1385.
|
| [24] |
Yue N, Huang H, Zhu X, et al. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippo-campal glial cells mediates chronic stress-induced depressive-like behaviors[J]. J Neuroinflammation, 2017, 14: 1-15.
|
| [25] |
Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone[J]. Cancer Res, 2005, 65: 9426-9435.
|
| [26] |
Jelassi B, Anchelin M, Chamouton J, et al. Anthraquin-one emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors[J]. Carcinogenesis, 2013, 34: 1487-1496.
|
